Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis.
<h4>Background</h4>Tuberculosis remains a major public health challenge for India. Various studies have documented different levels of TB and multi-drug resistant (MDR) TB among diverse groups of the population. In view of renewed targets set under the End TB strategy by 2035, there is a...
Saved in:
| Main Authors: | Sreenivas Achuthan Nair, Neeraj Raizada, Kuldeep Singh Sachdeva, Claudia Denkinger, Samuel Schumacher, Puneet Dewan, Shubhangi Kulsange, Catharina Boehme, Chinnambedu Nainarappan Paramsivan, Nimalan Arinaminpathy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0150054 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.
by: Kuldeep Singh Sachdeva, et al.
Published: (2015-01-01) -
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India.
by: Neeraj Raizada, et al.
Published: (2015-01-01) -
Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.
by: Sunil Khaparde, et al.
Published: (2017-01-01) -
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
by: Neeraj Raizada, et al.
Published: (2014-01-01) -
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
by: Kuldeep Singh Sachdeva, et al.
Published: (2015-01-01)